Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|1|14-22

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.1, 2012-01, pp. : 14-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel molecular targets for the therapy of urothelial carcinoma

By Jana Bagi RP   Galsky Matthew D   Hahn Noah M   Milowsky Matthew I   Sonpavde Guru  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 499-513

Informa Healthcare

Access to resources Recommend Favorite

Novel natural vanilloid receptor agonists: new therapeutic targets for drug development

By Sterner O.   Szallasi A.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 11, 1999-11 ,pp. : 459-465

Elsevier

Access to resources Recommend Favorite

PREFACE [Hot topic: Nuclear Hormone Receptor Modulators as Targets for Drug Discovery (Guest Editor: Timothy Grese)]

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 14, 2003-10 ,pp. : i-i

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear Receptors as Drug Targets: New Developments in Coregulators, Orphan Receptors and Major Therapeutic Areas

By Sladek Frances M  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 679-684

Informa Healthcare

Access to resources Recommend Favorite

The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma

By  

Current Drug Targets, Vol. 17, Iss. 2, 2016-02 ,pp. : 196-205

Bentham Science Publishers

Access to resources Recommend Favorite